Topix Pharmaceuticals, Inc. has acquired Derma E, a California-based eco-ethical skin care brand. The partnership with Topix will provide Derma E with additional resources to support its category-leading growth while expanding the Topix family of brands, and Topix’s commitment to advancing healthy, beautiful skin, into the increasingly important and high-growth naturals category.


Topix is backed by New Mountain Capital, a growth-oriented investment firm that currently manages more than $20 billion in assets. New Mountain Capital invested in Topix in July 2016 to provide equity capital for Topix to execute a growth strategy, including both organic and acquisition-led growth.


“We are thrilled to welcome Derma E into the Topix family,” said Andre Moura, managing director at New Mountain Capital and chairman of the Topix board of directors. “Topix is a leader in the dermatologist market with differentiated innovation and FDA-certified manufacturing capabilities. We look forward to supporting Derma E and its customers with these resources and believe the partnership will create multiple new avenues of long-term growth for both Derma E and the broader Topix business.”


Following the acquisition, Derma E will continue to operate in Simi Valley, CA.